Painreform is trading 5.8% down at $0.97, with no clear company-specific catalyst identified.

  • Painreform fell 14.17% to $1.03 on August 14, 2026.
  • No company-specific announcement, filing, earnings release, or overnight catalyst was found for August 17, 2026.
  • The latest PRF Technologies-specific report was June 25 preclinical PRF-110 data; broader markets were mixed.